Global Textile Implants Market Growing in Conjunction with the Development of Novel Materials and Designs :

Pune, India, February,2019/MRFR Press Release/- Market Research Future has published a half-cooked research report on the Global Textile Implants Market.


Use of textile implants is typical in orthopedic surgical procedures, hernia, eye surgeries, breast reconstruction, and cardiovascular surgeries. Technological advances in recent years have led to a variety of developments in textile implants which has allowed textile implants to serve greater purposes for s broader range of medical applications. Use of new materials for textile implants coupled with innovation in design, some of which are being designed for less-invasive surgeries, infection control, and expeditious healing has spurred the adoption of textile implants in medical procedures.

The global textile implants market is expected to showcase substantial growth over the forecast period of 2018-2023, asserts Market Research Future (MRFR) in a detailed report. The alarming rise in the prevalence of chronic diseases such as breast and prostate cancer has generated demand within the global textile implant market. Increase in orthopedic procedures and surge in sports-related injuries has initiated additional demand for textile implants.

Metal implants are prone to corrosion and can cause risk to patient's health which has encouraged the adoption of textile implants. Textile implants are produced in 2D or 3D forms which gives them the leverage of versatility. They can be customized to meet specific anatomical and biological requirements of patients. The ability of textile implants to cater to patient-specific and specialized end-user needs stimulates the growth of the global textile implants market.

With the introduction of resorbable textile implants, which break down in the body post implantation and textile implants becoming chemically interactive with body chemistries, they have emerged as an ideal option for the treatment of various medical conditions. Increasing research on textile implants and rise in the number of the aged population further augment the growth of the global textile implants market.

Contrarily, factors such as unfavorable reimbursement policies, product recall or failure, the high cost of implants and implantation procedures, and loss of tensile strength are likely to undermine the growth of the global textile implants market over the forecast period.

Browse Complete Report @


The global textile implants market has been segmented based on product type and end user.

By product type, the global textile implant market has been segmented into 2D implantable forms, 3D implantable forms, natural textile implants, and synthetic textile implants. The synthetic textile segment has been segmented into polyamide, polyester, polyethylene, polypropylene, resorbable polymers and non-resorbable polymers.

By end user, the global textile implant market has been segmented into  hospitals and clinics, ambulatory surgical centers, and others.    

Regional Analysis

By region, the global textile implants market has been segmented into North America, Europe, Asia Pacific, and the Middle EAst & Africa.

North America is leading the global textile implants market on account of surging prevalence of cardiovascular diseases, growing incidence rate of breast cancer, and growing breast reconstruction procedures.

Europe follows North America closely and is the second largest market for textile implants. The incraesing incidence rate of sports injuries and rise in a number of knee and hip replacement procedures favor the growth of the Europe textile implants market.

APAC is poised to be the fastest growing market for textile implants over the forecast period due to high healthcare expenditure and growing cases of cardiovascular diseases.

The MEA market will exhibit moderate growth over the forecast period due to low healthcare penetration and stringent government policies.

Competitive Landscape

The notable players in the global textile implant market include WL Gore, FX Solutions (France),

Mathys AG Bettlach (Switzerland), Xenotech, Orthomed S.A.S. (France), SERAG-WIESSNER GmbH & Co. KG Zum Kugelfang, LARS (France), Johnson and Johnson, Neoligaments (UK), Aran Biomedical, Shanghai PINE&POWER Biotech (China), and Surgicraft Inc., Cousin Biotech (France).